Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383059095> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W4383059095 endingPage "808" @default.
- W4383059095 startingPage "804" @default.
- W4383059095 abstract "To determine the factors affecting the frequency and severity of oral mucositis are following hematopoietic stem cell transplantation.Descriptive study. Place and Duration of the Study: Armed Forces Bone Marrow Transplant Centre Rawalpindi, from September 2020 to February 2022.Patients who underwent allogenic stem cell transplantation were enrolled. Patients were analysed based on history and examination for oral mucositis (OM) as per the WHO mucositis scale, from the start of conditioning chemotherapy till discharge, total duration of mucositis and type of medication were noted. Its association with risk factors like age, gender, conditioning chemotherapy, methotrexate (MTX) for GVHD prophylaxis, and prior history of irradiation was determined.Mean age of the 72 transplant recipients was 21.9 ± 14 years, with 48 males and 24 females. The common underlying diseases were beta-thalassemia major (30.6%, n=22), acute lymphoblastic leukaemia (n=15, 20.8%), aplastic anaemia (n=10, 13.9%), and multiple myeloma (n=8, 11.1%). The frequency of mucositis in those aged under 15 years was 79.3% (n=23) and in those older than 15 years was 74.4% (n=32). Frequency of mucositis was statistically significant in patients who received myeloablative conditioning regimen (85% vs. 20%, p <0.01), and who had prophylactic. MTX (91% vs. 48%, p<0.01) and who had prior craniospinal (CSI) radiation (100% vs. 70.2%, p=0.01). There was no statistical significance between stem cell dose (CD34/TNC) and mucositis. Severity of mucositis was significantly greater in Allogenic vs. auto HSCT (p=0.04). All the patients with mucositis required analgesics for pain management.Oral mucositis is a common but potentially debilitating complication of stem cell transplant, requiring opioid analgesia in a significant number of cases. Myeloablative conditioning, prophylactic MTX, and prior CSI are significantly associated with mucositis in transplant patients.Hematopoietic stem cell transplantation (HSCT), Oral Mucositis, Myeloablative conditioning, Methotrexate, Analgesia." @default.
- W4383059095 created "2023-07-05" @default.
- W4383059095 creator A5016096521 @default.
- W4383059095 creator A5016607253 @default.
- W4383059095 creator A5049164006 @default.
- W4383059095 creator A5066490238 @default.
- W4383059095 creator A5081694570 @default.
- W4383059095 creator A5088380959 @default.
- W4383059095 date "2023-07-01" @default.
- W4383059095 modified "2023-10-16" @default.
- W4383059095 title "Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation." @default.
- W4383059095 doi "https://doi.org/10.29271/jcpsp.2023.07.804" @default.
- W4383059095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37401225" @default.
- W4383059095 hasPublicationYear "2023" @default.
- W4383059095 type Work @default.
- W4383059095 citedByCount "0" @default.
- W4383059095 crossrefType "journal-article" @default.
- W4383059095 hasAuthorship W4383059095A5016096521 @default.
- W4383059095 hasAuthorship W4383059095A5016607253 @default.
- W4383059095 hasAuthorship W4383059095A5049164006 @default.
- W4383059095 hasAuthorship W4383059095A5066490238 @default.
- W4383059095 hasAuthorship W4383059095A5081694570 @default.
- W4383059095 hasAuthorship W4383059095A5088380959 @default.
- W4383059095 hasConcept C126322002 @default.
- W4383059095 hasConcept C141071460 @default.
- W4383059095 hasConcept C2776694085 @default.
- W4383059095 hasConcept C2776755627 @default.
- W4383059095 hasConcept C2777408962 @default.
- W4383059095 hasConcept C2778496288 @default.
- W4383059095 hasConcept C2778880498 @default.
- W4383059095 hasConcept C2911091166 @default.
- W4383059095 hasConcept C2993801483 @default.
- W4383059095 hasConcept C71924100 @default.
- W4383059095 hasConcept C90924648 @default.
- W4383059095 hasConceptScore W4383059095C126322002 @default.
- W4383059095 hasConceptScore W4383059095C141071460 @default.
- W4383059095 hasConceptScore W4383059095C2776694085 @default.
- W4383059095 hasConceptScore W4383059095C2776755627 @default.
- W4383059095 hasConceptScore W4383059095C2777408962 @default.
- W4383059095 hasConceptScore W4383059095C2778496288 @default.
- W4383059095 hasConceptScore W4383059095C2778880498 @default.
- W4383059095 hasConceptScore W4383059095C2911091166 @default.
- W4383059095 hasConceptScore W4383059095C2993801483 @default.
- W4383059095 hasConceptScore W4383059095C71924100 @default.
- W4383059095 hasConceptScore W4383059095C90924648 @default.
- W4383059095 hasIssue "7" @default.
- W4383059095 hasLocation W43830590951 @default.
- W4383059095 hasOpenAccess W4383059095 @default.
- W4383059095 hasPrimaryLocation W43830590951 @default.
- W4383059095 hasRelatedWork W2013451100 @default.
- W4383059095 hasRelatedWork W2316269512 @default.
- W4383059095 hasRelatedWork W2414302491 @default.
- W4383059095 hasRelatedWork W2775103135 @default.
- W4383059095 hasRelatedWork W2778222988 @default.
- W4383059095 hasRelatedWork W3028929821 @default.
- W4383059095 hasRelatedWork W3030542925 @default.
- W4383059095 hasRelatedWork W3031485523 @default.
- W4383059095 hasRelatedWork W3169113476 @default.
- W4383059095 hasRelatedWork W4383059095 @default.
- W4383059095 hasVolume "33" @default.
- W4383059095 isParatext "false" @default.
- W4383059095 isRetracted "false" @default.
- W4383059095 workType "article" @default.